May 08, 2018 09:28 am UTC| Business
Consolidated revenues € 366.5 million, +7.2%. EBITDA (1) € 134.4 million, +14.2% Operating income € 120.5 million, +12.4%. Net income € 86.6 million, +10.3%. Net financial position (2): net debt of € 484.6 million. ...
May 08, 2018 09:22 am UTC| Business
Rockville, MD, May 08, 2018 -- According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease...
Global Cardiovascular Partnering Deals Directory: Trends, Players and Financials 2012-2018
May 08, 2018 09:19 am UTC| Business
Dublin, May 08, 2018 -- The "Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Cardiovascular...
Winter Tires Market Remains Hotly Contested as a US$ 43 Billion Opportunity is in the Offing
May 08, 2018 09:10 am UTC| Business
Rockville, MD, May 08, 2018 -- The penetration of winter tires continues to gain ground in heavy commercial and light commercial vehicles – a trend that is complementing the steady demand from passenger cars segment....
Motion Control Market: Metal Cutting Application to Generate Significant Revenues through 2026
May 08, 2018 09:05 am UTC| Business
Rockville, MD , May 08, 2018 -- Growing need for faster production process of electronic products has led to an upsurge in demand for motion control systems globally. In addition, surge in demand for intelligent...
China Exhibition Industry Report 2018-2022
May 08, 2018 09:01 am UTC| Business
Dublin, May 08, 2018 -- The "Research Report on Exhibition Industry of China, 2018-2022" report has been added to ResearchAndMarkets.com's offering. Exhibitions can bring in visitors, material...
Affimed Announces First Quarter 2018 Financial Results and Corporate Update Conference Call
May 08, 2018 09:01 am UTC| Business
Heidelberg, Germany, May 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that on May 15, 2018,...